• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Iontophoretic application of prostaglandin E1 for the treatment of peripheral arterial occlusive disease

Research Project

Project/Area Number 09671222
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General surgery
Research InstitutionNagoya University

Principal Investigator

MATSUSHITA Masahiro  School of Medicine, Nagoya University, Research Associate, 医学部, 助手 (70273240)

Co-Investigator(Kenkyū-buntansha) NISHIKIMI Naomichi  School of Medicine, Nagoya University, Assistant Professor, 医学部, 講師 (40242862)
SAKURAI Tsunehisa  School of Medicine, Nagoya University, Associate Professor, 医学部, 助教授 (50144142)
Project Period (FY) 1997 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2000: ¥100,000 (Direct Cost: ¥100,000)
Fiscal Year 1999: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1998: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1997: ¥2,000,000 (Direct Cost: ¥2,000,000)
KeywordsIontophoresis / Prostaglandin E1 / Critical limb ischemia / プロスタグランディンE1 / プロスタグランデインE_1
Research Abstract

Prostaglandin E1 (PGE1) administered intra-arterially or intravenously has been used clinically in the treatment of peripheral arterial occlusive disease (PAOD). However, intraarterial infusion of PGE1 into an artery is invasive. Intravenous administration of PGE1 is less efficacious and may cause a steal phenomenon. We used iontophoresis to allow high concentrations of PGE1 to be delivered directly to the ischemic foot. Our in vitro study showed that PGE1 permeated through hairless mouse skin iontophoretically, but not by passive transport. Nineteen patients with Arteriosclerosis Obliterans were given PGE1 (20mg) iontophoretically on the dorsum of the foot. The increase rate in cutaneous blood flow as measured by Laser Doppler Flux (LDF) level was significantly higher in the PGE1 than in the control saline. The percent increase in LDF levels with PGE1 was similar in the patients with intermittent claudication and that in critical leg ischemia patients. The percent increase in LDF level was significantly higher with iontophoresis than with intravenous drip infusion of PGE1. Iontophoretic application of the PGE1 was used for the purpose of the treatment of an ischemic foot ulcer in 9 patients. Of those, 4 patients were treated successfully. The percent increase in LDF level was significantly higher in 4 patients treated successfully than in those with failed treatment. This preliminary study addressed the transdermal delivery of PGE1 and the microcirculatory effect of iontophoretically applied PGE1. Iontophoretically delivered PGE1 was beneficial in patients with ischemic ulcer if this treatment could increase blood flow of the skin close to the ulcer.

Report

(5 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (23 results)

All Other

All Publications (23 results)

  • [Publications] 山村恵子: "イオントフォレシス-prostaglandin E1投与の臨床応用-"Pharm Tech Japan. 13・7. 1021-1028 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Saeki S: "Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation"Ther Int J Clin Pharm. 36・10. 525-529 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 伊与田義信: "慢性虚血肢に対するIontophoresisの臨床応用"脈管学. 40・8. 465-471 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 伊与田義信: "四肢末梢血管疾患の薬物治療"医歯薬出版株式会社. 8 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamamura K: "Iontophoresis-Clinical apprecation of Prostaglandin E1-."Pharm Tech Japan. 13(7) (in Japanese). 1021-1028 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Saeki S: "Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation."Ther Int J Clin Pharm. 36(10). 525-529 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iyoda Y: "Clinical application of Iontophoresis to Chronic critical leg ischemia."J Jpn Coll Angiol. 40(8). 465-471 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iyoda Y: "Clinical application of Iontophoresis to peripheral arterial occlusive disease. In : Esato K, Zempo N editors. Pharmacological treatment of limb vascular disease. 1st ed."Tokyo : Ishiyaku Publishers. 234-241 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山村恵子: "イオントフォレシス-prostaglandin E1投与の臨床応用-"Pharm Tech Japan. 13・7. 1021-1028 (1997)

    • Related Report
      2000 Annual Research Report
  • [Publications] Saeki S: "Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation"Ther Int J Clin Pharm. 36・10. 525-529 (1998)

    • Related Report
      2000 Annual Research Report
  • [Publications] 伊与田義信: "慢性虚血肢に対するIontophoresisの臨床応用"脈管学. 40・8. 465-471 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 伊与田義信: "四肢末梢血管疾患の薬物治療"医歯薬出版株式会社. 8 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 佐伯悟三: "IontophoresisによるprostaglandinE_1の局所投与の経験"第14回東海プロスタグランヂン研究会(講師要旨集). 4 (1995)

    • Related Report
      1999 Annual Research Report
  • [Publications] 佐伯悟三: "閉塞性動脈硬化症に対するイオントフォレシスを用いたPGE_1療法"第16回東海プロスタグランヂン研究会(講師要旨集). 16 (1997)

    • Related Report
      1999 Annual Research Report
  • [Publications] 山村恵子: "イオントフォレシス-Prostaglandin E_1投与の臨床応用-"PHARM TECH JAPAN. 13・7. 1021-1028 (1997)

    • Related Report
      1999 Annual Research Report
  • [Publications] Satomi Saeki: "Iontophoretic application of prostaglandin E_1 for improvement in peripheral microcirculation."International Journal of Clinical Pharmacology and Therapeutics. 36・10. 525-529 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] 佐伯悟三: "IontophoresisによるprostaglandinE_1の局所投与の経験" 第14回東海プロスタグランヂン研究会(講演要旨集). 4 (1995)

    • Related Report
      1998 Annual Research Report
  • [Publications] 佐伯悟三: "閉塞性動脈硬化症に対するイオントフォレシスを用いたPGE_1療法" 第16回東海プロスタグランヂン研究会(講演要旨集). 16 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] 山本恵子: "イオントフォレシス-prostaglandin E_1投与の臨床応用" PHARM TECH JAPAN. 13・7. 1021-1028 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Satomi Saeki: "Iontophoretic application of prostaglandin. E_1 for improvement in peripheral microcirculation." International Journal of Clinical Pharmacology and Therapeutics. 36・10. 525-529 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 佐伯悟三: "IontophoresisによるprostaglandinE_1の局所投与の経験" 第14回東海プロスタグランヂン研究会(講演要旨集). 4- (1995)

    • Related Report
      1997 Annual Research Report
  • [Publications] 佐伯悟三: "閉塞性動脈硬化症に対するイオントフォレシスを用いたPGE_1療法" 第16回東海プロスタグランヂン研究会(講演要旨集). 16- (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 山村恵子: "イオントフォレシス-prostaglandinE_1投与の臨床応用" PHARM TECH JAPAN. 13・7. 1021-1028 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi